Stock listing

NASDAQ:OACCU Oaktree Acquisition Corp. III Life Sciences Stock

US listing (NASDAQ) of Oaktree Acquisition Corp. III Life Sciences · home listing NASDAQ:OACC

Follow Oaktree Acquisition Corp. III Life Sciences into a list and get an email when it puts out news.

Share price · NASDAQ:OACCU

$10.76 USD +0.01 (+0.1%)

Close on Nov 20, 2026

Past year +1.4% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
$10.76 – $10.76 USDNov 20, 2026
52-week range
$10.65 – $12.47 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$583 USDMedian day 0 shares · 52 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Oaktree Acquisition Corp. III Life Sciences logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:OACC · Home$10.71 USD-0.01 (-0.1%)491$10.71$10.71$10.71$10.72Close on Nov 20, 2026
NASDAQ:OACCU$10.76 USD+0.01 (+0.1%)—$10.76$10.76$10.76$10.75Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · NASDAQ:OACCU · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.800.000.0%$10.80$10.80$10.800
$10.80-0.06-0.6%$10.80$10.80$10.80100
$10.860.000.0%$10.86$10.86$10.860
$10.860.000.0%$10.86$10.86$10.860
$10.86-0.14-1.3%$10.89$10.89$10.862,100
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.00+0.09+0.8%$11.00$11.00$11.00100
$10.91-0.089-0.8%$10.92$10.92$10.90700
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
Ticker
NASDAQ:OACCU
Asset type
Fund
Sector
Financials
Industry
Shell companies & SPACs
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Oaktree Acquisition Corp. III Life Sciences news

Oaktree Acquisition Corp. III Life Sciences on 6ix

Sector
Financials
Industry
Shell companies & SPACs
News releases
2 in the last 12 months · 7 in all · newest May 13, 2026 · oldest 2025

Where Oaktree Acquisition Corp. III Life Sciences is listed

ListingExchangeCountryCurrency
NASDAQ:OACC · Home listingNASDAQUnited StatesUSD
BOATS:OACCBOATSUnited StatesUSD
NASDAQ:OACCU · This pageNASDAQUnited StatesUSD

Valuation

P/E 32.7× against a median of 38.5×: 2nd lowest of 5 Shell companies & SPACs companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$140.7M USD
P/E
32.7×
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta vs S&P 500
0.02

Shell companies & SPACs: the 10 companies nearest in size, of 284 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Oaktree Acquisition Corp. III Life Sciences · NASDAQ:OACCUS$141.9MUS$140.7M32.7×n/an/an/an/an/a0.02
TGE Value Creative Solutions Corp · NYSE:BEBEUS$151.3MUS$151.3M40.6×n/an/an/an/an/an/a
Leapfrog Acquisition Corporation · NASDAQ:LFACUS$150.4MUS$149.5Mn/an/an/an/an/an/a-0.02
Aperture AC · NASDAQ:APURUS$149.1MUS$148.9Mn/an/an/an/an/an/an/a
APEX Tech Acquisition Inc. · NYSE:TRADUS$148.1MUS$148.1M202×n/an/an/an/an/a0.02
Andretti Acquisition Corp. II · NASDAQ:POLEUS$148.1MUS$147.9M23.1×n/an/an/an/an/a0.01
K2 Capital Acquisition Corporation · NASDAQ:KTWOUS$143.1MUS$142.3Mn/an/an/a275×n/a0.0×0.03
XFLH Capital Corporation · NYSE:XFLHUS$141.4MUS$141.1Mn/an/an/a340×n/a0.0×0.05
RF Acquisition Corp III · NASDAQ:RFAMUS$139.8MUS$138.9Mn/an/an/a235×n/a0.0×-0.01
Chenghe Acquisition III Co. · NASDAQ:CHECUS$134.9MUS$134.5M36.4×n/an/an/an/an/a0.03
Blue Water Acquisition Corp. IV · NYSE:BWIVUS$134.4MUS$134.4Mn/an/an/an/an/an/a0.00
Median of the othersUS$145.6MUS$145.1M38.5×275×0.0×0.02

Team and board

Officers

OfficerRole
Zaid PardesiCEO and Director
George MartinezCFO
Mathew PendoCOO

Board

DirectorRole
Aman KumarChairman
Alvin ShihDirector
David BerryDirector
Paul MeisterDirector
Zaid PardesiCEO and Director

Events

QuarterResultsShare move
Q3 2025Nov 13, 20250.0%
Q2 2025Aug 12, 2025+0.6%
Q1 2025May 14, 2025−0.1%
Q3 2024Oct 4, 2024

Open Events

IPO

A blank check company (SPAC). Priced at US$10.00 a unit on Oct 23, 2024.

Price
US$10.00 a unit
Units offered
17,500,000 units
Offering size
US$175 million
Underwriters' option
Up to 2,625,000 more units
Underwriters
Jefferies, Citigroup, UBS Investment Bank · In the order on the cover
Units delivered
On or about Oct 25, 2024

Steps

StepWhen
Draft sent to the SEC in confidenceAug 7, 2024
Filed publiclyOct 4, 2024
Amended onceOct 18, 2024
Shares registered with an exchangeOct 23, 2024
Declared effective by the SECOct 23, 2024
Final prospectus, with the priceOct 24, 2024

Open IPO · From the cover of the final prospectus (424B4) filed Oct 24, 2024

Financials

Annual, in USD

Income statement

LineFY2025
Operating income-1.20M
Net income7.29M

Balance sheet

LineFY2025
Cash and equivalents1.43M
Current assets1.55M
Total assets203.1M
Current liabilities1.30M
Total liabilities8.32M
Shareholders' equity-6.77M

Cash flow

LineFY2025
Cash from operations-422.1K
Cash from investing500.0K
Cash from financing0
Change in cash77.9K

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 13, 2026Quarterly reportSEC
8-K · Current reportOct 26, 2026Meeting outcomeSEC
4 · Change in ownershipOct 23, 2026Insider tradeSEC
DEFA14A · Additional proxy materialOct 16, 2026Meeting noticeSEC
8-K · Current reportOct 16, 2026Current reportSEC
DEFA14A · Additional proxy materialOct 15, 2026Meeting noticeSEC
8-K · Current reportOct 15, 2026Current reportSEC
DEF 14A · Proxy statementOct 2, 2026Meeting noticeSEC
All 69 filings
FilingDateTypeFiled with
PRE 14A · Preliminary proxy statementSep 21, 2026Meeting noticeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 13, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeMay 11, 2026Big-stake noticeSEC
10-K · Annual reportMar 26, 2026Annual reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 11, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
3 · Initial statement of ownershipOct 29, 2025Insider tradeSEC
8-K · Current reportOct 29, 2025Management or board changeSEC
3 · Initial statement of ownershipOct 22, 2025Insider tradeSEC
8-K · Current reportOct 17, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 12, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 15, 2025Big-stake noticeSEC
3 · Initial statement of ownershipJun 16, 2025Insider tradeSEC
8-K · Current reportJun 6, 2025Management or board changeSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 13, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 9, 2025Big-stake noticeSEC
10-K · Annual reportMar 27, 2025Annual reportSEC
SCHEDULE 13G · Big-stake noticeFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 12, 2025Big-stake noticeSEC
8-K · Current reportJan 7, 2025Management or board changeSEC
8-K · Current reportDec 11, 2024Current reportSEC
SC 13G · Big-stake noticeNov 7, 2024Big-stake noticeSEC
8-K · Current reportNov 5, 2024FinancingSEC
4 · Change in ownershipOct 31, 2024Insider tradeSEC
8-K · Current reportOct 31, 2024Current reportSEC
SC 13G · Big-stake noticeOct 30, 2024Big-stake noticeSEC
8-K · Current reportOct 25, 2024Material contractSEC
424B4 · ProspectusOct 24, 2024Offer documentSEC
CERT · Exchange's certificate of listingOct 24, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveOct 24, 2024Other filingsSEC
3 · Initial statement of ownershipOct 23, 2024Insider tradeSEC
3 · Initial statement of ownershipOct 23, 2024Insider tradeSEC
3 · Initial statement of ownershipOct 23, 2024Insider tradeSEC
3 · Initial statement of ownershipOct 23, 2024Insider tradeSEC
3 · Initial statement of ownershipOct 23, 2024Insider tradeSEC
3 · Initial statement of ownershipOct 23, 2024Insider tradeSEC
3 · Initial statement of ownershipOct 23, 2024Insider tradeSEC
3 · Initial statement of ownershipOct 23, 2024Insider tradeSEC
8-A12B · Registration of shares for listing on an exchangeOct 23, 2024Other filingsSEC
CORRESP · Letter to the SECOct 21, 2024Other filingsSEC
CORRESP · Letter to the SECOct 21, 2024Other filingsSEC
CORRESP · Letter to the SECOct 18, 2024Other filingsSEC
S-1/A · Registration statement, amendedOct 18, 2024Offer documentSEC
UPLOAD · Letter from the SECOct 18, 2024Other filingsSEC
CORRESP · Letter to the SECOct 4, 2024Other filingsSEC
S-1 · Registration statementOct 4, 2024Offer documentSEC
UPLOAD · Letter from the SECOct 1, 2024Other filingsSEC
DRSLTR · Letter to the SEC with a draftSep 13, 2024Other filingsSEC
DRS/A · Draft registration statement, amendedSep 13, 2024Offer documentSEC
UPLOAD · Letter from the SECSep 5, 2024Other filingsSEC
DRS · Draft registration statementAug 6, 2024Offer documentSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Oaktree Acquisition Corp. III Life Sciences’ releases

Common shares
13,250,666
Fully diluted
13,250,666

Fully diluted

LineShares
Common shares13,250,666

Share count over time

CountShares
Nov 22, 202613,250,666

Open Cap table

Shareholders

Institutions

HolderSharesValueChange vs Jun 30Filed
Fort Baker Capital Management LP1.54MUS$16.6M+437KNov 16, 2026
AQR Arbitrage LLC1.32MUS$14.2MNo changeNov 16, 2026
Decagon Asset Management LLP1.26MUS$13.6M+172KNov 16, 2026
Empyrean Capital Partners, LP900KUS$9.68MNo changeNov 16, 2026
D. E. Shaw & Co., Inc.862KUS$9.27MNo changeNov 16, 2026
Boussard & Gavaudan Gestion Sas720KUS$7.76MNo changeNov 12, 2026
Linden Advisors LP600KUS$6.46MNo changeNov 16, 2026
TD541KUS$5.83M−13,733Nov 16, 2026
Sculptor Capital LP531KUS$5.72MNo changeNov 13, 2026
Goldman Sachs530KUS$5.69MNo changeNov 16, 2026
All 50 holders
HolderSharesValueChange vs Jun 30Filed
Moore Capital Management, LP525KUS$5.66MNo changeNov 16, 2026
ADAR1 Capital Management, LLC516KUS$5.62MNewNov 16, 2026
LMR Partners LLP511KUS$5.51MNo changeNov 16, 2026
Alberta Investment Management Corp500KUS$5.38MNo changeNov 9, 2026
Verition Fund Management LLC472KUS$5.08M+1,766Nov 13, 2026
Healthcare Of Ontario Pension Plan Trust Fund450KUS$4.84MNo changeNov 13, 2026
Ghisallo Capital Management LLC450KUS$4.84MNo changeNov 19, 2026
Two Sigma438KUS$4.7MNo changeNov 16, 2026
Radcliffe Capital Management, L.P.387KUS$4.18MNo changeNov 16, 2026
O'Connor Alternative Investments, LLC373KUS$4.01M+73,046Nov 16, 2026
Periscope Capital Inc.323KUS$3.49M+8Nov 6, 2026
Glazer Capital, LLC300KUS$3.24M−57,549Nov 16, 2026
Tenor Capital Management Company, L.P.300KUS$3.23MNo changeNov 16, 2026
Governors Lane LP300KUS$3.24MNo changeNov 16, 2026
Shaolin Capital Management LLC285KUS$3.07M+84,453Nov 13, 2026
Affinity Asset Advisors, LLC250KUS$2.72MNewNov 13, 2026
Whitebox Advisors LLC250KUS$2.69MNo changeNov 16, 2026
Lineage Point Capital LP233KUS$2.51MNo changeNov 16, 2026
Berkley W R Corp224KUS$2.41MNo changeNov 16, 2026
Hudson Bay Capital Management LP200KUS$2.15M−100KNov 13, 2026
Gritstone Asset Management LLC195KUS$2.1M−200KOct 26, 2026
Millennium175KUS$1.89MNo changeNov 16, 2026
DLD Asset Management, LP168KUS$1.81M+2,791Nov 13, 2026
Schonfeld Strategic Advisors LLC145KUS$1.56M+29Nov 16, 2026
K2 Principal Fund, L.P.115KUS$1.23M−251KNov 13, 2026
BNP Paribas81,520US$876KNo changeNov 12, 2026
Picton Mahoney Asset Management75,000US$809KNo changeNov 9, 2026
Mizuho Securities USA LLC64,576US$681K+23,407Nov 17, 2026
Athos Capital Ltd50,000US$550KNewNov 12, 2026
JPMorgan49,958US$537K+26Nov 12, 2026
Citigroup Inc45,000US$484KNo changeNov 4, 2026
Clear Street Group Inc.43,243US$469K+22,243Nov 16, 2026
UBS38,763US$418K+37,183Nov 10, 2026
Rangeley Capital, LLC37,827US$408K−2,412Nov 16, 2026
Readystate Asset Management LP25,000US$269KNo changeNov 16, 2026
Geode Capital15,243US$164KNo changeNov 6, 2026
Kepos Capital LP15,000US$162KNo changeNov 12, 2026
Bulldog Investors, LLP13,500US$145KNo changeNov 16, 2026
Warberg Asset Management LLC10,037US$108KNo changeNov 2, 2026
Torno Capital, LLC1US$11NewNov 16, 2026

Funds

HolderSharesValueChangeAs of
Destinations Multi Strategy Alternatives Fund480KUS$5.07MFirst reportFeb 28, 2026
Horizon Kinetics SPAC Active ETF50,006US$536KNo changeJun 30, 2026
Fidelity Nasdaq Composite Index Fund15,243US$162KNo changeMay 31, 2026

Big stakes

HolderStakeSharesDate
Oaktree Acquisition Holdings III LS, LLC22.30%5.5MDec 31, 2024
Fort Baker Capital Management LP7.80%1.54MSep 30, 2026
AQR Capital Management LLC7.33%1.45MMar 31, 2025
Barclays PLC6.99%1.38MJun 30, 2026
Decagon Asset Management LLP6.39%0Sep 30, 2026
Goldman Sachs Group Inc6.20%1.23MMar 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Paul Meister
Other companies: Versigent PLC (Director · Since at least Apr 1, 2026); Amneal Pharmaceuticals, Inc. (Chairman of the Board · Since at least Aug 2, 2019); Aptiv PLC (Lead Independent Director · Since at least Jul 25, 2019); Quanterix Corporation (Director · Since at least Dec 6, 2017); Telesis Bio, Inc. (Director · Jun 5, 2023 – Jun 6, 2023 · Past); Oaktree Acquisition II Corp (Director · Sep 16, 2020 – Sep 16, 2020 · Past); Hims & Hers Health, Inc. (Director · Jul 17, 2019 – Jul 17, 2019 · Past); Revlon Inc (Director · Jun 9, 2016 – Jun 9, 2016 · Past); vTv Therapeutics Inc. (Director · Jul 30, 2015 – Jul 30, 2015 · Past); Light & Wonder, Inc. (Director · Mar 20, 2012 – Jun 10, 2020 · Past); M & F Worldwide Corp (Director · Apr 30, 2007 – Dec 21, 2011 · Past); Thermo Fisher Scientific Inc (Director · Nov 9, 2006 – Jan 5, 2007 · Past); LKQ Corporation (Director · Mar 31, 2006 – May 8, 2017 · Past); Fisher Scientific International Inc (Vice Chairman, Director · Jan 13, 2006 – Nov 9, 2006 · Past)
Director · Oct 23, 2024 – Oct 23, 2024 · Past
John B. Frank
Other companies: Daily Journal Corp. (S.C.) (Director · Since at least Oct 3, 2025); Chevron Corporation (Board Member · Since at least Nov 2, 2017); Oaktree Specialty Lending Corporation (Director and Chairman · Since at least Oct 17, 2017); Oaktree Acquisition II Corp (Director · Sep 16, 2020 – Sep 16, 2020 · Past); Hims & Hers Health, Inc. (Director · Jul 17, 2019 – Jul 17, 2019 · Past); Oaktree Strategic Income Corporation (Director · Oct 17, 2017 – Mar 19, 2021 · Past); Brookfield Oaktree Holdings, LLC (Vice Chairman, Director · Apr 9, 2012 – Sep 30, 2019 · Past)
Director · Oct 23, 2024 – Oct 23, 2024 · Past
Mathew Pendo
Other companies: Oaktree Acquisition II Corp (Chief Operating Officer · Sep 16, 2020 – Sep 16, 2020 · Past); Hims & Hers Health, Inc. (Chief Operating Officer · Jul 17, 2019 – Jul 17, 2019 · Past); Oaktree Specialty Lending Corporation (President · Oct 17, 2017 – Feb 24, 2025 · Past); Oaktree Strategic Income Corporation (President and COO · Oct 17, 2017 – Mar 19, 2021 · Past); Supervalu Inc (Director · Apr 24, 2014 – Oct 22, 2018 · Past); Ally Financial Inc. (Director · Apr 9, 2014 – May 28, 2015 · Past)
Chief Operating Officer · Oct 23, 2024 – Oct 23, 2024 · Past
David Berry
Other companies: Averin Capital Acquisition Corp. (See Remarks, Director · Since at least Feb 18, 2026); Omega Therapeutics Inc (Director · Jul 29, 2021 – Aug 3, 2021 · Past); Axcella Health Inc (Director · May 8, 2019 – May 20, 2020 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – Jun 8, 2016 · Past); Fortune Industries Inc (Director · May 18, 2007 – Mar 19, 2013 · Past)
Director · Since at least Oct 17, 2025
Alvin Shih
Other companies: Zevra Therapeutics, Inc. (Director · Since at least Jan 20, 2024); Travere Therapeutics, Inc. (EVP of Research & Development · May 29, 2014 – Sep 1, 2016 · Past)
Director · Oct 23, 2024 – Oct 23, 2024 · Past
Zaid Pardesi
Other companies: Oaktree Acquisition II Corp (See Remarks · Sep 16, 2020 – Sep 16, 2020 · Past); Hims & Hers Health, Inc. (Chief Financial Officer · Oct 1, 2019 – Oct 1, 2019 · Past)
Chief Executive Officer · Oct 23, 2024 – Oct 23, 2024 · Past
Aman KumarDirector · Oct 23, 2024 – Oct 23, 2024 · Past
Courtney ConigliaroChief Financial Officer · Oct 23, 2024 – Oct 23, 2024 · Past
George MartinezChief Financial Officer · Since at least Oct 29, 2025
Thomas SweeneyChief Financial Officer · Since at least Jun 3, 2025

Open People

Log in to ask 6ix AI your own questions about Oaktree Acquisition Corp. III Life Sciences.